Chloroprocaine 2% vs Ropivacaine 0.75% in Ultrasound-guided Axillary Nerve Block

Clinical trial NCT02385097 · COMPLETED

Trial details

NCT number: NCT02385097
Sponsor: Sintetica SA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Axillary Nerve Block

Start date: 2015-04-01
Primary completion: 2017-05-01
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.